She is having history of sickle cell disease and lmp = 3/9/2025
Tell me she is ready to deliver baby
Reading File
Finding Sources
Searching PubMed
sickle cell disease pregnancy delivery management
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Now I have enough information to provide a comprehensive answer. Let me interpret the clinical note and give a full assessment.
Gestational Age & EDD Calculation
Interpreting the LMP: If LMP = 9/3/2025 (September 3, 2025, which is the most likely format given "3/9/2025" in DD/MM/YYYY notation common in South Asia):
- By Naegele's Rule: EDD = LMP + 9 months + 7 days = June 10, 2026
- Today = June 2, 2026
- Gestational age = ~38 weeks + 6 days ≈ 39 weeks - she is at TERM and ready to deliver
If LMP = March 9, 2025 (MM/DD format), EDD would be December 16, 2025 - she would be well post-dates, which doesn't clinically fit. So 9 March 2025 (DD/MM) is the correct interpretation.
Reading the Clinical Note (Image)
The handwritten prescription/note appears to include:
| Item | Interpretation |
|---|---|
| Pena 2cc Im | Likely Pethidine (Pena = Pethidine?) 2cc IM - opioid analgesia for labor pain |
| at intervals of 12 hrs | Dosing frequency - 12 hourly IM |
| 2nd dose | She has already received one dose |
| Ct Tramadol (x) 50 combo | Continue Tramadol 50 mg combination - additional pain management |
| 110/70 P/A | Blood pressure 110/70 mmHg, per abdomen examination |
| Ct feum | Continue Ferrous (iron supplementation) |
| Hydroxyurea (Kyflodel?) | May indicate status on hydroxyurea (should be stopped in pregnancy) |
| FHS f | Fetal Heart Sounds - present (favorable) |
| USG scan | Ultrasound ordered |
| Admt today | Admit today |
| CM | Likely consultant/attending signature |
Clinical Assessment: Sickle Cell Disease in Labour at ~39 Weeks
Is She Ready to Deliver?
YES - she is at term (~39 weeks) and should be managed for delivery.
Key Intrapartum Management Principles
1. Mode of Delivery
- Vaginal delivery is preferred if no obstetric contraindications
- Regional (spinal/epidural) anesthesia is strongly preferred over general anesthesia, as general anesthesia increases post-partum sickling complications
- Cesarean section is reserved for obstetric indications (fetal distress, failure to progress, malpresentation, etc.)
2. Pain Management (as seen in the note)
- The note shows IM opioid analgesia (pethidine/tramadol) - appropriate for labor pain
- Avoid NSAIDs after 30 weeks gestation (already contraindicated at term)
- Epidural analgesia is ideal if available - reduces pain-triggered sickling
3. Hydration & Oxygenation
- Maintain IV fluids (avoid dehydration - key trigger for sickling)
- Supplemental oxygen to keep SpO2 >95%
- Avoid cold environments (vasoconstriction triggers crisis)
4. Blood Monitoring
- CBC, reticulocyte count, cross-match and hold
- Target Hb ~10 g/dL; if <7 g/dL or symptomatic - transfuse
- Goal: Hb S < 40% if exchange transfusion considered
5. Transfusion Considerations
- Therapeutic transfusion indicated for: symptomatic anemia, acute chest syndrome, intrapartum hemorrhage, preeclampsia, cardiopulmonary instability
- Target Hb ~10 g/dL, HbS < 40%
6. DVT Prophylaxis
- Women with SCD have 1.7-10x higher risk of VTE in pregnancy
- Low molecular weight heparin (LMWH) prophylaxis post-delivery
7. Fetal Monitoring
- Continuous CTG (FHS noted as present in the note - reassuring)
- Ultrasound (ordered - look for growth restriction, placental insufficiency)
8. Medications to AVOID in Labour
- Hydroxyurea (teratogenic - should already be stopped)
- NSAIDs at term
- Ergometrine (causes vasoconstriction - avoid; use oxytocin for 3rd stage instead)
9. Post-Delivery
- Maintain hydration, oxygenation post-delivery
- Watch for acute chest syndrome (post-partum complication)
- Continue thromboprophylaxis for at least 6 weeks post-partum
- Resume hydroxyurea after delivery and breastfeeding cessation
Complications to Watch For
| Maternal | Fetal/Neonatal |
|---|---|
| Vaso-occlusive crisis | Preterm birth (less risk at 39 weeks) |
| Acute chest syndrome | IUGR / low birth weight |
| Preeclampsia (BP monitoring essential) | Placental insufficiency |
| VTE / DVT | Perinatal mortality (reduced with good care) |
| Postpartum hemorrhage | Neonatal screening for SCD |
BP in the note = 110/70 mmHg - this is normal and reassuring.
Summary
At ~39 weeks with sickle cell disease, this patient is at term and ready for delivery. She should be admitted, managed with:
- IV hydration + supplemental O2
- Regional anesthesia preference
- Opioid analgesia for labour pain (as already prescribed)
- Continuous fetal monitoring (CTG)
- Crossmatch blood, have transfusion on standby
- Avoid NSAIDs, ergometrine, and general anesthesia if possible
- Plan vaginal delivery unless obstetric indication for CS arises
Sources: Goldman-Cecil Medicine (Management of Pregnancy in SCD); Rosen's Emergency Medicine (Sickle Cell Anemia in Pregnancy, p.3377); PMID 35950054 (Systematic Review, 2022)
This is a shared conversation. Sign in to Orris to start your own chat.